Lab marker
PSA
Prostate-specific antigen
Men's most-discussed and most-controversial tumour marker, useful but only in the context of informed shared decision-making.
What it measures
A serine protease produced almost exclusively by prostate epithelial cells. Elevated by prostate cancer but also by benign prostatic hyperplasia, prostatitis, recent ejaculation, urinary tract infection, and prostate manipulation (DRE, biopsy, cycling). Reported in ng/mL.
Reference context
2 guideline sources
Single PSA values are noisy; repeat after 4–6 weeks before action, and exclude transient causes (ejaculation, UTI, vigorous exercise). PSA velocity (rate of change) and PSA density (PSA / prostate volume on MRI) refine interpretation. The Stockholm3 test combines PSA with other biomarkers and kallikreins to reduce unnecessary biopsies; ERSPC follow-up has confirmed a prostate-cancer mortality reduction with organised screening, now reported at 23 years (13% relative reduction; one death prevented per 456 men invited), alongside overdiagnosis.
Population context: consult guideline targets below
Mechanism
Why moving this marker matters
Prostate cancer cells leak PSA more freely than normal prostate tissue. Population screening has been shown to reduce prostate-cancer mortality (ERSPC, Göteborg) but at the cost of substantial overdiagnosis and overtreatment of indolent cancers that would never have caused harm. The evidence balance has been the subject of major guideline revisions over the past decade.
Guideline targets
What major guidelines recommend
Common reference (general adult action threshold)
>3 ng/mL → consider further evaluation (mpMRI, repeat testing). >4 ng/mL has been the historical biopsy threshold but is now considered too aggressive.
Age-specific reference ranges (Oesterling 1993, rough guide)
<2.5 ng/mL under 50; <3.5 ng/mL 50–59; <4.5 ng/mL 60–69; <6.5 ng/mL 70+. Not a reason to ignore a rising PSA.
How to measure
The test, where to get it, when to repeat
Method
Standard blood draw. Avoid ejaculation in the 48 hours before testing; avoid testing within 6 weeks of UTI, prostatitis, biopsy, or vigorous cycling.
Where
GP request or private lab. Germany: GKV covers DRE from 45; PSA usually self-pay. UK: not offered as routine screening. US: shared decision-making, typically from age 50–55, earlier with risk factors.
Typical cost
€20–50 private; coverage varies (screening PSA is usually self-pay in Germany).
Fasting
Not required
When to test
USPSTF 2018
55–69maleGrade C (individual decision) for men 55–69; Grade D (recommend against) for men 70+. Understanding the overdiagnosis trade-off is central to the decision.
EAU 2024
50+maleRisk-adapted screening from age 50 (or 45 with family history / African ancestry). Multiparametric MRI before biopsy if PSA elevated.
ACS 2024
maleShared decision-making from age 50; from 45 with elevated risk (family history, African American men).
Where to test
Independent labs offering this test
Healicus refers you to independent laboratories. You order from the lab; they take the sample, run it, and return your result on their own platform. Healicus never sees your value.
Randox Health
UK · EU · INTLClinic-based premium panels — wider biomarker breadth than home-test brands.
Visit Randox Health
Synlab
DE · EU · INTLEurope-wide medical lab network — referrals via partner GPs and direct-to-consumer programmes where offered.
Visit Synlab
Medichecks
UKUKAS-accredited home blood-test panels with GP-equivalent biomarker coverage.
Visit Medichecks
Quest Diagnostics
USDirect-to-consumer ordering via Quest's patient portal — same lab the US healthcare system uses.
Visit Quest Diagnostics
Healicus is not the provider. Your contract for the service is with whoever you choose. Links labelled Sponsored are paid affiliate relationships; unlabelled links are editorial reference only. See our disclosure for the full policy.
Context
Reading the numbers
Single PSA values are noisy; repeat after 4–6 weeks before action, and exclude transient causes (ejaculation, UTI, vigorous exercise). PSA velocity (rate of change) and PSA density (PSA / prostate volume on MRI) refine interpretation. The Stockholm3 test combines PSA with other biomarkers and kallikreins to reduce unnecessary biopsies; ERSPC follow-up has confirmed a prostate-cancer mortality reduction with organised screening, now reported at 23 years (13% relative reduction; one death prevented per 456 men invited), alongside overdiagnosis.
Caveats
PSA screening's benefits and harms balance differently for different men; informed discussion before testing is the standard of care, not optional. A PSA above threshold typically leads to mpMRI before biopsy in modern protocols; this has substantially reduced unnecessary biopsy rates. 5-alpha-reductase inhibitors (finasteride, dutasteride) roughly halve PSA. Tell your doctor if you take them.
Practices
What's been shown to influence this marker
A 2019 systematic review for the US physical activity guidelines found only moderate or limited evidence linking more physical activity with lower mortality after a prostate cancer diagnosis; any effect on PSA values is not established.
In a large US cohort (Health Professionals Follow-up Study), Mediterranean-diet adherence was not associated with advanced or lethal prostate cancer; among men already diagnosed, closer adherence was associated with lower overall mortality. Effects on PSA itself are not established.
A meta-analysis of observational studies (Zhao 2016) reported a dose-related association between alcohol intake and prostate cancer risk; effects on PSA values are not established.
CautionHabitLimit alcohol intake
Meta-analysis of 107 cohort studies: drinking 45 g or more of alcohol a day was linked to higher all-cause mortality, while low-volume drinking showed no significant difference.
Why
A 2023 JAMA Network Open meta-analysis of 107 cohort studies (n=4,838,825) found higher all-cause mortality in people drinking 45 g or more of alcohol per day than in lifetime nondrinkers, with women at higher risk. Low-volume drinking showed no significant mortality difference once biases were corrected, so light drinking is not shown to be protective. The US Preventive Services Task Force advises screening and brief counselling for adults who drink above recommended limits.
How to do it
How
Track intake honestly for one week. If above threshold, set a weekly cap rather than a daily one (avoids the 'I'll catch up' trap). Several alcohol-free days per week is the simplest pattern. Sleep quality typically improves within 1-2 weeks of reduced intake.
Ideal for
Anyone currently drinking heavily or above recommended limits.
Markers this may influence
Evidence
Zhao 2023 JAMA Netw Open meta-analysis of 107 cohort studies (n=4,838,825): drinkers of 45 g or more of alcohol per day had higher all-cause mortality than lifetime nondrinkers (RR 1.19 and 1.35), while low-volume drinking showed no significant difference. The US Preventive Services Task Force (2018) recommends screening adults and offering brief counselling to those drinking above recommended limits.
GRADE certainty: Low — rated by Healicus using the GRADE method
- GBD 2016 Alcohol Collaborators, Lancet 2018, global burden of alcohol use in 195 countries; minimum-risk consumption is zero
- Zhao J et al., Association Between Daily Alcohol Intake and Risk of All-Cause Mortality: A Systematic Review and Meta-analyses, JAMA Netw Open 2023
- Ronksley PE et al., Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis, BMJ 2011
- USPSTF guideline (2018): Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions (2018)
HabitMediterranean dietary pattern
Olive oil, fish, nuts, legumes, plants. Two randomised trials found fewer major cardiovascular events than a low-fat diet.
Why
The Mediterranean pattern, heavy on plants, olive oil, fish, nuts, legumes; moderate fish and dairy; light on red meat, has randomised-trial evidence for fewer major cardiovascular events than a low-fat diet in adults at high cardiovascular risk. PREDIMED, the largest trial (republished after protocol deviations), showed ~30% fewer major cardiovascular events vs. low-fat control. Trial evidence for cognition is thin.
Slot in your day
How to do it
How
Olive oil as the primary fat. Plants at every meal. Fish 2–3× per week. Nuts daily (small handful). Red meat once a week or less. Alcohol is not needed for the pattern; low-volume drinking has not been shown to be protective.
Sticking with it
Stock the kitchen for one week's pattern. Decisions live in the shopping list, not at mealtime.
Markers this may influence
Evidence
Estruch 2018 N Engl J Med RCT (n=7,447, adults at high cardiovascular risk, republished after protocol deviations): a Mediterranean diet with olive oil or nuts had fewer major cardiovascular events than a control diet advising less fat (hazard ratios 0.69 and 0.72). Delgado-Lista 2022 Lancet RCT (n=1,002, coronary heart disease) found a similar direction versus a low-fat diet, mainly in men. Trial evidence for cognition is thin.
GRADE certainty: Moderate — rated by Healicus using the GRADE method (RCT evidence; downgraded for protocol deviations/no blinding in the main trials and for indirectness of dietary-pattern comparisons)
- Estruch et al., NEJM 2018 (PREDIMED)
- Estruch R et al., Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts, N Engl J Med 2018
- Delgado-Lista J et al., Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial, Lancet 2022
- Rees K et al., Mediterranean-style diet for the primary and secondary prevention of cardiovascular disease, Cochrane Database Syst Rev 2019
- Dinu M et al., Mediterranean diet and multiple health outcomes: an umbrella review of meta-analyses of observational studies and randomised trials, Eur J Clin Nutr 2018
- Sofi F et al., Adherence to Mediterranean diet and health status: meta-analysis, BMJ 2008
- Psaltopoulou T et al., Mediterranean diet, stroke, cognitive impairment, and depression: A meta-analysis, Ann Neurol 2013
- Valls-Pedret C et al., Mediterranean Diet and Age-Related Cognitive Decline: A Randomized Clinical Trial, JAMA Intern Med 2015
- Petersson SD, Philippou E, Mediterranean Diet, Cognitive Function, and Dementia: A Systematic Review of the Evidence, Adv Nutr 2016
- NICE guideline (2020): Acute Coronary Syndromes Guideline (NG185) — Secondary Prevention Visual Summary
- USPSTF guideline (2020): Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions
HabitZone 2 cardio
Conversational-pace cardio, 150+ minutes per week, in line with WHO's moderate-intensity guideline.
Why
Zone 2 is the intensity at which you can still hold a conversation but a song would be a stretch, roughly 60–70% of max heart rate. This exact intensity has not been tested; WHO strongly recommends 150–300 minutes a week of moderate-intensity aerobic activity for adults, and cohort studies link that kind of activity to lower all-cause mortality. Sustained Zone 2 work is proposed to increase mitochondrial density and improve fat oxidation.
Slot in your day
How to do it
How
Brisk walk, easy bike, slow jog. 30 minutes × 5 days, or 45–60 min × 3 days. The 'talk test' is the simplest gauge.
Ideal for
Anyone over 30; especially valuable as the foundation before adding higher-intensity work.
Sticking with it
Schedule it like a meeting. The session you 'fit in if there's time' is the session that doesn't happen.
Markers this may influence
Evidence
WHO's 2020 physical activity guidelines strongly recommend 150-300 minutes a week of moderate-intensity aerobic activity for adults, on moderate-certainty evidence of lower all-cause and cardiovascular mortality. Kelly 2014 Int J Behav Nutr Phys Act meta-analysis of cohort studies: about 11 MET-hours a week of walking or cycling was associated with 11% and 10% lower all-cause mortality. The specific 'zone 2' intensity was not tested.
GRADE certainty: Moderate — reported by WHO 2020 guidelines (moderate certainty for aerobic activity of 150-300 min/week)
Take to your physician
Worth discussing
- Whether PSA screening makes sense for you given your age, family history, ethnicity, and personal values about overdiagnosis risk.
- If PSA is elevated, what the workup path looks like (repeat, mpMRI, potentially biopsy) before assuming the worst.
- If diagnosed with prostate cancer, whether active surveillance is appropriate for indolent disease (most early-stage cancers detected by screening qualify).
Sources
Cited literature
- [1]USPSTF 2018, Screening for prostate cancer(2018)
- [2]EAU Guidelines on Prostate Cancer 2024, Screening and early detection(2024)
- [3]Schröder et al., Screening and prostate cancer mortality: results of the ERSPC at 13 years of follow-up (Lancet)(2014)
- [4]Hugosson et al., Eighteen-year follow-up of the Göteborg randomized population-based prostate cancer screening trial (Scand J Urol)(2018)
- [5]Roobol et al., European Study of Prostate Cancer Screening, 23-year follow-up (NEJM)(2025)
- [6]Oesterling et al., Serum prostate-specific antigen in a community-based population of healthy men: establishment of age-specific reference ranges (JAMA)(1993)
- [7]American Cancer Society, Prostate Cancer Early Detection Guideline(2024)
- [8]McTiernan et al., Physical activity in cancer prevention and survival: a systematic review (Med Sci Sports Exerc)(2019)
- [9]Kenfield et al., Mediterranean diet and prostate cancer risk and mortality in the Health Professionals Follow-up Study (Eur Urol)(2014)
- [10]Zhao et al., Alcohol consumption and prostate cancer risk: a dose-response meta-analysis (BMC Cancer)(2016)
Last reviewed October 2026
Keep reading
← Previous
Lab marker
Albumin
The body's most abundant blood protein, a quiet marker of nutritional status, hepatic synthesis, and inflammatory state. Lower values predict mortality across populations.
Next →
Lab marker
Vitamin B12
Essential cofactor for DNA synthesis and methylation; deficiency is common, often subtle, and slowly reversible.